17th ANNUAL CONFERENCE of the German Society for Neuromodulation
Between the 4th and 5th of November, we’ll be at the 17th ANNUAL CONFERENCE of the German Society for Neuromodulation at: Victor’s Residenz-Hotel GeraBerliner Strasse 3807545 Gera More information here: https://www.medical-communications.de/veranstaltungen/17-jahrestagung-der-deutschen-gesellschaft-fuer-neuromodulation-ev
MRI Approval for directSTIM™ DBS System
Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System Lausanne, Switzerland, 14 September 2022 – Aleva Neurotherapeutics SA, the company that pioneered Directional Deep Brain Stimulation (DBS) in Neuromodulation, announces the CE approval of its MRI labeling for the directSTIM™ DBS System, to be used in a full-body magnetic resonance imaging […]
We’re Hiring – Software Engineer & Project Manager
In order to support our continued growth, we are looking for a Medical Device Software Project Manager and a Software Engineer. Medical Device Software Project Manager: Bachelor degree in Computer Science (or related field) with at least 9 years of experience or Master’s degree with at least 7 years of related experience (HES or EPFL). […]
FDA Grants Aleva Approval for IDE Study
U.S. FDA grants Aleva Neurotherapeutics approval for an Investigational Device Exemption (IDE) study on directSTIM™ Directional Deep Brain Stimulation System Aleva is committed to starting the PMA trial in the next quarters, in parallel with the post-market clinical follow-up study currently underway in select European neurological clinics. The US trial will include up to 15 […]